Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 27, Pages 23236-23245Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M112.368779
Keywords
-
Categories
Funding
- Ministry of Health Labour and Welfare
- Takeda Science Foundation
- Novo Nordisk Insulin Research Foundation
- Banyu Life Science Foundation International
- Japan Diabetes Foundation
- International Priority Graduate Programs Advanced Graduate Courses for International Students, Ministry of Education, Culture, Sports, Science, and Technology in Japan
- Grants-in-Aid for Scientific Research [20117001, 24790932, 23126521, 20117005, 21220010] Funding Source: KAKEN
Ask authors/readers for more resources
Mutations of the HNF4A gene cause a form of maturity-onset diabetes of the young (MODY1) that is characterized by impairment of pancreatic beta-cell function. HNF4 alpha is a transcription factor belonging to the nuclear receptor superfamily (NR2A1), but its target genes in pancreatic beta-cells are largely unknown. Here, we report that ankyrin repeat and sterile alpha motif domain containing 4b (Anks4b) is a target of HNF4 alpha in pancreatic beta-cells. Expression of Anks4b was decreased in both beta HNF4 alpha KO islets and HNF4 alpha knockdown MIN6 beta-cells, and HNF4 alpha activated Anks4b promoter activity. Anks4b bound to glucose-regulated protein 78 (GRP78), a major endoplasmic reticulum (ER) chaperone protein, and overexpression of Anks4b enhanced the ER stress response and ER stress-associated apoptosis of MIN6 cells. Conversely, suppression of Anks4b reduced beta-cell susceptibility to ER stress-induced apoptosis. These results indicate that Anks4b is a HNF4 alpha target gene that regulates ER stress in beta-cells by interacting with GRP78, thus suggesting that HNF4 alpha is involved in maintenance of the ER.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available